![{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID in PDB entry 2pdn, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/2pdn_entity_3_side_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>2pdn</span> contains 1 copy of <span class='highlight'>{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID</span>. Side view.")
![{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID in PDB entry 2pdn, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/2pdn_entity_3_top_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>2pdn</span> contains 1 copy of <span class='highlight'>{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID</span>. Top view.")
Environment details NEW
47D 600 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.